AHF's Mobile Billboard Calls Out Gilead's Greed at Pharma Summit

Core Viewpoint - The AIDS Healthcare Foundation (AHF) is launching a mobile billboard to criticize Gilead Sciences for its pricing strategy regarding the HIV prevention drug lenacapavir, demanding that it be made affordable and accessible [1] Group 1: Company Actions - AHF's mobile billboard will circle the venue of the Global Pharma & Biotech Summit in London on November 11-12 [1] - The billboard carries a message directed at Gilead and its CEO Daniel O'Day, urging them to "Make Lenacap" [1] Group 2: Industry Context - The event coincides with the Global Pharma & Biotech Summit, highlighting ongoing discussions in the pharmaceutical industry regarding drug pricing and accessibility [1]